Total planned funding: $326,071,900
Allocations
Countries/Regions
Eswatini | $326,071,900 |
Organizational Types
Private Contractor | $88,289,025 |
University | $58,805,573 |
NGO | $54,595,510 |
Unknown | $50,810,827 |
Own Agency | $41,379,394 |
FBO | $13,230,009 |
Host Country Government Agency | $10,514,978 |
Multi-lateral Agency | $7,109,130 |
Other USG Agency | $1,167,854 |
Implementing Agency | $169,600 |
Program Areas
Care | $98,784,437 |
Treatment | $85,805,685 |
Prevention | $61,863,872 |
Governance and Systems | $29,922,032 |
Testing | $25,475,594 |
Management and Operations | $24,220,280 |
Budget Codes
HTXS: Treatment: Adult Treatment | $69,123,636 |
HBHC: Care: Adult Care and Support | $41,467,027 |
HKID: Care: Orphans and Vulnerable Children | $35,902,880 |
HVCT: Testing: HIV Testing and Counseling | $25,475,594 |
HVMS: Management and Operations | $24,220,280 |
HVOP: Sexual Prevention: Other Sexual Prevention | $24,177,217 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $20,488,069 |
OHSS: Health Systems Strengthening | $14,125,519 |
HVTB: Care: TB/HIV | $12,973,197 |
HVSI: Strategic Information | $10,693,302 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,730,048 |
HTXD: Treatment: ARV Drugs | $9,609,456 |
PDCS: Care: Pediatric Care and Support | $8,441,333 |
PDTX: Treatment: Pediatric Treatment | $7,072,593 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,538,567 |
HLAB: Laboratory Infrastructure | $5,103,211 |
HMBL: Biomedical Prevention: Blood Safety | $1,929,971 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$49,072,197
Countries/Regions
Pact, Inc.:
$40,108,623
Countries/Regions
Not Available:
$32,500,961
Countries/Regions
Chemonics International:
$22,700,973
Countries/Regions